Everolimus
NDC 70377-092, Everolimus, tablet, for suspension, from Biocon Pharma Inc..
- Product NDC
- 70377-092
- Status
- Listed
- Labeler
- Biocon Pharma Inc.
- Dosage form
- TABLET, FOR SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA217216
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70377-092 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- EVEROLIMUS5 mg/1
Pharmacologic classes
Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; Decreased Immunologic Activity [PE]; Kinase Inhibitor [EPC]; Protein Kinase Inhibitors [MoA]; mTOR Inhibitor Immunosuppressant [EPC]; mTOR Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70377-092-11 | 70377009211 | 28 TABLET, FOR SUSPENSION in 1 BOTTLE (70377-092-11) |
| 70377-092-23 | 70377009223 | 4 BLISTER PACK in 1 CARTON (70377-092-23) / 7 TABLET, FOR SUSPENSION in 1 BLISTER PACK |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/5b809dfe-c076-07c5-207e-178c3f0d32d3
Use it
Look up 70377-092 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70377-092 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70377-092. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.